GRFS
NEUTRAL
$8.21
Live
Grifols, S.A. · NASDAQ
Target $11.1
(+35.2%)
$6.84
52W Range
$11.14
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Confidence
80%
GRFS presents a classic 'value trap' profile: strong deterministic health (Piotroski F-Score 7/9) and deep valuation discounts (Price < Graham Number < Intrinsic Value), yet it suffers from severe market rejection. While the stock trades at a significant discount to its Graham Number of $11.36 and Intrinsic Value of $18.88, this is offset by a 0/100 technical trend and a dismal earnings track record with 0 beats in the last 4 quarters. The disconnect between strong operational health scores and poor price performance suggests systemic risks or lack of catalyst for a reversal.
Key Strengths
Strong Piotroski F-Score (7/9) indicating improving operational efficiency
Deep value valuation with P/B (0.92) and P/S (0.90) both under 1.0
Significant upside to Graham Number ($11.36) and Intrinsic Value ($18.88)
Strong recent earnings growth (YoY 43.50%)
Healthy current ratio (2.51) providing a short-term liquidity buffer
Key Risks
Severe earnings miss trend (Average surprise -27.42% over last 4 quarters)
Stagnant top-line growth (Revenue growth YoY only 0.30%)
Bearish technical momentum (Technical Trend score 0/100)
Quick ratio (0.84) suggests reliance on inventory for liquidity
Weak insider sentiment (40/100) indicating lack of internal confidence
AI Fair Value Estimate
Based on comprehensive analysis
$12.1
+47.4% above current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare GRFS against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning GRFS from our newsroom.
Newest → oldest
No matching news yet.